| Literature DB >> 23460907 |
Jielu Ling1, Haizhu Pan, Qingqing Gao, Liping Xiong, Yefei Zhou, Debao Zhang, Song Gao, Xiufan Liu.
Abstract
Aerobactin genes are known to be present in virulent strains and absent from avirulent strains, but contributions of iucC and iucA, which are involved in aerobactin synthesis, to the pathogenicity of avian pathogenic Escherichia coli (APEC) have not been clarified. In this study, effects of double mutants (iucA/iutA or iucC/iutA) compared to those of single mutants (iucA, iucC or iutA) of aerobactin genes on the virulence of APEC strain E058 were examined both in vitro (aerobactin production, ingestion into HD-11 cells, survival in chicken serum) and in vivo (competitive growth against parental strain, colonization and persistence). In competitive co-infection assays, compared to the E058 parental strain, the E058ΔiucA mutant was significantly reduced in the liver, kidney, spleen (all P<0.01), heart and lung (both P<0.001). The E058ΔiutA mutant also was significantly reduced in the liver, lung, kidney (all P<0.01), heart and spleen (both P<0.001). The E058ΔiucC mutant was significantly attenuated in the heart and kidney (both P<0.05) and showed a remarkable reduction in the liver, spleen and lung (P<0.01); meanwhile, both E058ΔiucAΔiutA and E058ΔiucCΔiutA double mutants were sharply reduced as well (P<0.001). In colonization and persistence assays, compared with E058, recovered colonies of E058ΔiucA were significantly reduced from the lung, liver, spleen and kidney (P<0.01) and significantly reduced in the heart (P<0.001). E058ΔiutA was significantly reduced from the heart, lung, liver, spleen and kidney (P<0.01). E058ΔiucC, E058ΔiucAΔiutA and E058ΔiucCΔiutA were significantly decreased in all organs tested (P<0.001). These results suggest that iutA, iucA and iucC play important roles in the pathogenicity of APEC E058.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23460907 PMCID: PMC3584046 DOI: 10.1371/journal.pone.0057794
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Strains, plasmids and cell line used in this study.
| Description | Source | |
|
| ||
| E058 | Wild-type avian |
|
| DH5α | endA1 hsdR17 (rk −mk +)supE44 thi-1 recA1 gyrA (NalR) RelA1Δ(lacIZYA-argF) U169deoR (φ80d lac Δ (lacZ) M15) | Invitrogen |
| LG1522 | Aerobactin indicator strain |
|
| E058Δ |
| This study |
| E058Δ |
| This study |
| E058Δ |
| This study |
| E058Δ |
| This study |
| E058Δ |
| This study |
| Re-E058Δ | Complementation of E058Δ | This study |
| Re-E058Δ | Complementation of E058Δ | This study |
|
| ||
| pMD®18-T simple vector | TA cloning vector, ApR | Promega |
| pT- |
| This study |
| pT- |
| This study |
| pBluescript II SK(-) | Cloning vector | Fermentas |
| pS- |
| This study |
| pS- |
| This study |
| pEM7/Zeo | Zeocin-resistant cassette | Invitrogen |
| pUC4K | Kanamycin-resistant cassette | Invitrogen |
| pS- | Zeocin-resistant gene inserted into pS- | This study |
| pS- | Zeocin-resistant gene inserted into pS- | This study |
| pGEX-6P-1 | Bacterial expression vector | Amersham |
| pGEX-6P-1- |
| This study |
| pGEX-6P-1- |
| This study |
|
| ||
| HD-11 | Chicken macrophage line, chicken myelomonocytic transformed by the myc-encoding MC29 virus |
|
Primers designed and used in this study.
| Primer name | Sequence 5′–3′ | Position (bp) | Source |
| iutA-F |
| 33–51 | This study |
| iutA-R |
| 1981–1999 | This study |
| iucA-F |
| 44–61 | This study |
| iucA-R |
| 1556–1573 | This study |
| pS-iucA-F |
| 492–509 | This study |
| pS-iucA-R |
| 1200–1217 | This study |
| iucC-F |
| 14–31 | This study |
| iucC-R |
| 1715–1732 | This study |
| Zeo-BamH I-F |
| 1938–1955 | This study |
| Zeo-BamH I-R |
| 2366–2383 | This study |
| GF |
| 114–131 | This study |
| GR |
| 266–283 | This study |
| BF |
| 701–718 | This study |
| BR |
| 921–938 | This study |
| DF |
| 782–799 | This study |
| DR |
| 1181–1198 | This study |
| O2F |
| 1–19 | This study |
| O2R |
| 204–222 | This study |
| Re-iucA-F |
| 1–18 | This study |
| Re-iucA-R |
| 1708–1725 | This study |
| Re-iucC-F |
| 1–18 | This study |
| Re-iucC-R |
| 1726–1743 | This study |
Figure 1Detection of iucA (A, B), iucC (D, E) and iutA (C, F) gene expression by RT-PCR.
(A). Detection of iucA gene transcription in E058 and E058ΔiucA by RT-PCR. Templates: lanes 1, 3, 5: cDNA derived from total RNA of E058. Lane 7: total RNA from E058 without activation of RT. Lanes 8, 10, 12: cDNA derived from total RNA of E058ΔiucA. Lane 14: total RNA from E058ΔiucA without activation of RT. Lanes 2, 4, 6: pAPEC-O2-ColV-like DNA from E058. Lanes 9, 11, 13: pAPEC-O2-ColV-like DNA from E058ΔiucA. Primers: Lanes 1, 2, 8, 9: GF/GR. Lanes 3, 4, 10, 11: iucA-F/iucA-R. Lanes 5, 6, 7, 12, 13, 14: BF/BR (Table 2). (B). Detection of iucA gene transcription in E058 and E058ΔiucAΔiutA by RT-PCR. Templates: lanes 1, 3, 5: cDNA derived from total RNA of E058. Lane 7: total RNA from E058 without activation of RT. Lanes 8, 10, 12: cDNA derived from total RNA of E058ΔiucAΔiutA. Lane 14: total RNA from E058ΔiucAΔiutA without activation of RT. Lanes 2, 4, 6: pAPEC-O2-ColV-like DNA from E058. Lanes 9, 11, 13: pAPEC-O2-ColV-like DNA from E058ΔiucAΔiutA. Primers: Lanes 1, 2, 8, 9: GF/GR. Lanes 3, 4, 10, 11: iucA-F/iucA-R. Lanes 5, 6, 7, 12, 13, 14: BF/BR (Table 2). (C). Detection of iutA gene transcription in E058 and E058ΔiucAΔiutA by RT-PCR. Templates: lanes 1, 3, 5: cDNA derived from total RNA of E058. Lane 7: total RNA from E058 without activation of RT. Lanes 8, 10, 12: cDNA derived from total RNA of E058ΔiucAΔiutA. Lane 14: total RNA from E058ΔiucAΔiutA without activation of RT. Lanes 2, 4, 6: pAPEC-O2-ColV-like DNA from E058. Lanes 9, 11, 13: pAPEC-O2-ColV-like DNA from E058ΔiucAΔiutA. Primers: Lanes 1, 2, 8, 9: DF/DR. Lanes 3, 4, 10, 11: iutA-F/iutA-R. Lanes 5, 6, 7, 12, 13, 14: O2F/O2R (Table 2). (D). Detection of iucC gene transcription in E058 and E058ΔiucC by RT-PCR. Templates: lanes 1, 3, 5: cDNA derived from total RNA of E058. Lane 7: total RNA from E058 without activation of RT. Lanes 8, 10, 12: cDNA derived from total RNA of E058ΔiucC. Lane 14: total RNA from E058ΔiucC without activation of RT. Lanes 2, 4, 6: pAPEC-O2-ColV-like DNA from E058. Lanes 9, 11, 13: pAPEC-O2-ColV-like DNA from E058ΔiucC. Primers: Lanes 1, 2, 8, 9: BF/BR. Lanes 3, 4, 10, 11: iucC-F/iucC-R. Lanes 5, 6, 7, 12, 13, 14: DF/DR (Table 2). (E). Detection of iucC gene transcription in E058 and E058ΔiucCΔiutA by RT-PCR. Templates: lanes 1, 3, 5: cDNA derived from total RNA of E058. Lane 7: total RNA from E058 without activation of RT. Lanes 8, 10, 12: cDNA derived from total RNA of E058ΔiucCΔiutA. Lane 14: total RNA from E058ΔiucCΔiutA without activation of RT. Lanes 2, 4, 6: pAPEC-O2-ColV-like DNA from E058. Lanes 9, 11, 13: pAPEC-O2-ColV-like DNA from E058ΔiucCΔiutA. Primers: Lanes 1, 2, 8, 9: BF/BR. Lanes 3, 4, 10, 11: iucC-F/iucC-R. Lanes 5, 6, 7, 12, 13, 14: DF/DR (Table 2). (F). Detection of iutA gene transcription in E058 and E058ΔiucCΔiutA by RT-PCR. Templates: lanes 1, 3, 5: cDNA derived from total RNA of E058. Lane 7: total RNA from E058 without activation of RT. Lanes 8, 10, 12: cDNA derived from total RNA of E058ΔiucCΔiutA. Lane 14: total RNA from E058ΔiucCΔiutA without activation of RT. Lanes 2, 4, 6: pAPEC-O2-ColV-like DNA from E058. Lanes 9, 11, 13: pAPEC-O2-ColV-like DNA from E058ΔiucCΔiutA. Primers: Lanes 1, 2, 8, 9: DF/DR. Lanes 3, 4, 10, 11: iutA-F/iutA-R. Lanes 5, 6, 7, 12, 13, 14: O2F/O2R (Table 2). A 200 bp marker (Takara) was used as the molecular size standard (M).
Figure 2Growth curves of E058 wild-type strain and its mutants.
(A) The E058(□), E058ΔiutA(▪), E058ΔiucA(▴), E058ΔiucC(×), E058ΔiucAΔiutA (*) and E058ΔiucCΔiutA (•) strains were grown in LB broth at 37°C, respectively, and their growth curves were determined by measuring viable counts (CFU ml−1). (B) Growth curves of the E058 and its mutants in LB containing 200 µM 2,2′-dipyridyl (DIP). The data represent averages of three independent assays.
Figure 3Bactericidal activity of SPF chicken serum against the wild type strain and mutants.
Strains E058 (black bar), E058ΔiutA (white bar), E058ΔiucA (gray bar), E058ΔiucAΔiutA (gray dots), E058ΔiucC (gray oblique lines), E058ΔiucCΔiutA (gray grids). HI represents the group of heat-inactivated 25% SPF chicken serum used as controls for each strain tested. Data represent averages of three independent assays.
Figure 4Competition assays between wild-type E058 and mutants E058ΔiutA, E058ΔiucA, E058ΔiucC, E058ΔiucAΔiutA or E058ΔiucCΔiutA inoculated simultaneously.
Negative competitive index (CI) values indicate a decreased capacity of the mutants to compete for growth with the wild-type strain. Horizontal bars indicate the mean log10CI values. Each data point represents a sample from an individual chicken. Statistically significant differences in CI values between E058 and its mutants are indicated with asterisks (* P<0.05, ** P<0.01, *** P<0.001).
Figure 5Colonization and persistence of wild-type strain E058 and its mutants E058ΔiutA, E058ΔiucA, E058ΔiucC, E058ΔiucAΔiutA and E058ΔiucCΔiutA.
Data are presented as log10 CFU.g−1 of bacteria from tissues, and horizontal bars represent mean values. Each data point represents a sample from an individual chicken. Statistically significant differences are indicated with asterisks (** P<0.01, *** P<0.001), as determined by the Mann Whitney U test.